Plasma C5a and serum C5aR levels in patients with chronic spontaneous urticaria: A single-center case-control study
PLOS One · 26.06.2026 · 21 (6) · e0351329
DOI: 10.1371/journal.pone.0351329 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift PLOS One, online erschienen am 26.06.2026. Verfasst von Thao T Pham und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hanoi Medical University, Hanoi, Vietnam. Hauptthemen laut MEDLINE: Chronic Urticaria, Receptor, Anaphylatoxin C5a, Complement C5a, Urticaria. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
C5a and its receptor, C5aR, are involved in the degranulation of mast cells and basophils, leading to the release of proinflammatory cytokines. However, to date, their roles in the pathogenesis of chronic spontaneous urticaria (CSU) remain incompletely understood.
Objective
To investigate the association of plasma C5a and serum C5aR with disease severity in Vietnamese patients with CSU.
Methods
A case-control study was conducted involving 146 patients with CSU and 30 healthy adults matched by age and sex (the matching ratio ~ 5:1), at the Urticaria clinic, National Hospital of Dermatology and Venereology, Vietnam. Plasma C5a and serum C5aR levels were measured using the ELISA technique, and disease severity was assessed using the Urticaria Activity Score over 7 days (UAS7). The associations between C5a/C5aR with disease severity and several patient’s characteristics were evaluated using Spearman’s correlation and logistic regression.
Results
Plasma C5a levels were significantly increased in CSU patients compared to healthy controls (p < 0.001), whereas serum C5aR levels in CSU patients were significantly reduced (p < 0.001). A significant positive correlation was found between disease severity based on UAS7 scores and plasma C5a levels (Spearman’s rho = 0.63, p < 0.001), but not for serum C5aR levels (Spearman’s rho = 0.05, p = 0.527). A C5a level of 4335 pg/mL was defined as the optimal cutoff points for identifying severe CSU with an AUC of 0.86 (95% CI: 0.80–0.92, p < 0.001), sensitivity of 64%, and specificity of 100%. Several factors were found to be associated with C5a and C5aR levels, such as prothrombin time and anti-TPO antibodies.
Conclusions
CSU patients demonstrate elevated plasma C5a and reduced serum C5aR levels compared to healthy controls. While plasma C5a may serve as a potential biomarker for indicating CSU severity, C5aR levels show no significant association with the disease severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Hanoi Medical University, Hanoi, Vietnam.
- National Hospital of Dermatology and Venereology, Hanoi, Vietnam.
ORCID-Profile: Minh N Vu, Thuong V Nguyen, Phuong T M Pham
Zitieren
APA
Pham, T. T., Vu, M. N., Le, M. H., Le, D. H., Nguyen, T. V., & Pham, P. T. M. (2026). Plasma C5a and serum C5aR levels in patients with chronic spontaneous urticaria: A single-center case-control study. PLOS One, 21(6), e0351329. https://doi.org/10.1371/journal.pone.0351329
Vancouver
Pham TT, Vu MN, Le MH, Le DH, Nguyen TV, Pham PTM. Plasma C5a and serum C5aR levels in patients with chronic spontaneous urticaria: A single-center case-control study. PLOS One. 2026;21(6):e0351329. doi:10.1371/journal.pone.0351329
BibTeX
@article{Pham2026,
author = {Pham, Thao T and Vu, Minh N and Le, My H and Le, Doanh H and Nguyen, Thuong V and Pham, Phuong T M},
title = {Plasma C5a and serum C5aR levels in patients with chronic spontaneous urticaria: A single-center case-control study},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {6},
pages = {e0351329},
doi = {10.1371/journal.pone.0351329}
}
EUVIMED